A very revealing thread regarding the last AZD0466 poster presentation a few months before the AZD0466 program was paused and then terminated, which in turn led to a massive leg down in the share price.
It’s obvious which posters couldn’t see the woods from the trees. Imagine an investment strategy based on sticking your fingers in your ears and saying I can’t hear you.
Had been hoping that AZ might put another DEP into the clinic but unfortunately with every month that passes it’s looking more and more unlikely.
Ann: AZD0466 Clinical Data Presented by AstraZeneca EHA Congress, page-80
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.8¢ | $67.06K | 673.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 150305 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 21082 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.8¢ | 355338 | ||
| Last updated 14.59pm 07/06/2024 ? | |||||
| SPL (ASX) Chart |